Prospective Study
Copyright ©The Author(s) 2016.
World J Gastrointest Pharmacol Ther. Feb 6, 2016; 7(1): 145-155
Published online Feb 6, 2016. doi: 10.4292/wjgpt.v7.i1.145
Table 2 Severity of heartburn and regurgitation was significantly improved in both groups during the study, with significant difference between the 2 subgroups
Incomplete responders
Complete responders
Visit interval(subject number)Median (IQR)P value
Visit interval(subject number)Median (IQR)P value
Baseline ON-PPIBaseline OFF-PPIBaseline ON-PPIBaseline OFF-PPI
Percent diary days with heartburn severityBaseline OFF PPI (14)Baseline OFF PPI (6)
12 mo (15)< 0.00112 mo (6)0.03
24 mo (12)< 0.00124 mo (7)0.03
NoneBaseline OFF PPI (14)0 (0-10)Baseline OFF PPI (6)0 (0-14)
12 mo (15)88 (42-100)12 mo (6)83 (54-100)
24 mo (12)86 (73-100)24 mo (7)79 (32-93)
MildBaseline OFF PPI (14)19 (14-29)Baseline OFF PPI (6)14 (0-14)
12 mo (15)0 (0-32)12 mo (6)0 (0-25)
24 mo (12)7 (0-14)24 mo (7)7 (0-18)
ModerateBaseline OFF PPI (14)46 (31-66)Baseline OFF PPI (6)62 (46-68)
12 mo (15)0 (0-7)12 mo (6)0 (0-11)
24 mo (12)0 (0-7)24 mo (7)7 (0-29)
Baseline OFF PPI (14)11 (0-29)Baseline OFF PPI (6)8 (4-21)
Severe12 mo (15)0 (0-0)12 mo (6)0 (0-1)
24 mo (12)0 (0-0)24 mo (7)0 (0-4)
% Diary days with regurgitation severityBaseline OFF PPI (14)Baseline OFF PPI (6)0.030.03
12 mo (15)< 0.00312 mo (6)
24 mo (12)< 0.0324 mo (7)
NoneBaseline OFF PPI (14)35 (7-70)Baseline OFF PPI (6)4 (0-8)
12 mo (15)100 (100-100)12 mo (6)   100 (100-100)
24 mo (12)100 (95-100)24 mo (7)100 (86-100)
MildBaseline OFF PPI (14)8 (7-20)Baseline OFF PPI (6)19 (9-54)
12 mo (15)0 (0-0)12 mo (6)0 (0-0)
24 mo (12)0 (0-0)24 mo (7)0 (0-4)
ModerateBaseline OFF PPI (14)30 (4-57)Baseline OFF PPI (6)29 (11-46)
12 mo (15)0 (0-0)12 mo (6)0 (0-0)
24 mo (12)0 (0-0)24 mo (7)0 (0-4)
Baseline OFF PPI (14)0 (0-21)Baseline OFF PPI (6)0 (0-16)
Severe12 mo (15)0 (0-0)12 mo (6)0 (0-0)
24 mo (12)24 mo (7)0 (0-0)